BenevolentAI SPAC Presentation Deck
How Benevolent Is Revolutionising Drug Discovery
Knowledge
Built with scientists
for scientists
Introspection
tools enable
real-time in-silico
experimentation
ww
High-confidence hypothesis-driven drug discovery
The Benevolent PlatformTM is a scientifically-validated computational
R&D platform that supports end-to-end Al-enabled drug discovery
and development
2 Target Identification
Sign
Disease
Target
↓
Can we treat T2DM by reversing
insulin resistance in adipocytes by
reducing oxidative stress?
Mechanism
Precision Medicine
Endpoint: What
we are measuring
in the assay
AD
Cell type
Molecular Design
Empowers scientists to:
✔ Decipher complex disease biology
✔ Discover novel targets
✔ Run in-silico experiments in real time
✔ Accelerate the development of
drug candidates
Make high confidence decisions
✔ Increase the probability of
discovering a successful drug
Benevolent 12View entire presentation